Author(s): Santi Sinala

Email(s): santisinala@poltekkes-mks.ac.id

DOI: 10.52711/0974-360X.2026.00224   

Address: Santi Sinala*
Department of Pharmacy, Poltekkes Kemenkes Makassar, South of Sulawesi, Indonesia.
*Corresponding Author

Published In:   Volume - 19,      Issue - 4,     Year - 2026


ABSTRACT:
The solubility of the active substance in the preparation base determines the level of the active substance that can reach the target cells. Many active drug substances have a low level of solubility in body solvents. In fact, the solubility property is a requirement for the active substance to work in side effects. Ketoprofen (KPN) is a BCS Class II drug compound that has a very low level of solubility in water, which is 0.010mg/ml. Dengen bark extract (EKBD) also has low solubility in water because contain active compounds that are lipophilic (insoluble in water) or hydrophobic, which can be difficult to dissolve in conventional solvents. This study aims to help the solubility of KPN and EKBD in solvents other than organic solvents. The method used is to use the Deep Eutecticum Solvents (DESs) system, namely a binary mixture of fatty acids and menthol, namely Lauric Acid, Stearic Acid, Palmitic Acid, Myristic Acid with the concentration ratio between fatty acids and menthol is 1:1, 0.25:1, 0.5:1, 2:1, 1:2, 1:0.5, 1:0.25. Characterization is carried out including the level of solubility using a UV Vis spectrophotometer; viscosity, determination of changes in functional groups using FTIR and XRD. The results showed a mixture of lauric acid and menthol at a concentration ratio of 1:1; 0.25:1; 0.5:1; 1:2 produces clear liquid at various temperatures. While mixtures of other types of fatty acid do not produce a clear solution, and even do not dissolve in each other. The results show that consecutively at ratio 1:1; 0.25:1; 0.5:1; 1:2 for KPN was 10, 02mg/mL (99,15%), 9, 53mg/mL (94,34%), 10, 04mg/mL (99,42%) dan 10, 67mg/mL (105,63%). While for EKBD was 6,92mg/mL (82,19%), 3,50mg/mL (41,51%), 6,77mg/L (80, 37%), 7,51mg/mL (89,14%). The viscosity value is in accordance with the provisions, and there is no change in the structure of functional groups either from measurements with FTIR and XRD. Based on the result, it can be concluded that the good binary mixture with KPN and EKBD both in formula 4 (lauric acid : menthol = 1:2).


Cite this article:
Santi Sinala. Deep Eutectic System Based on Fatty Acids and Menthol as an Alternative Green Solvent in Increasing the Solubility of Ketoprofen and Dengen Bark Extract. Research Journal of Pharmacy and Technology. 2026;19(4):1567-6. doi: 10.52711/0974-360X.2026.00224

Cite(Electronic):
Santi Sinala. Deep Eutectic System Based on Fatty Acids and Menthol as an Alternative Green Solvent in Increasing the Solubility of Ketoprofen and Dengen Bark Extract. Research Journal of Pharmacy and Technology. 2026;19(4):1567-6. doi: 10.52711/0974-360X.2026.00224   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-4-13


REFERENCE:
1.    Santone A, Cesarelli M, Colasuonno E, Bevilacqua V, Mercaldo F. A Method for Ocular Disease Diagnosis through Visual Prediction Explainability. Electronics. 2024 Jul 10; 13(14): 2706. https://doi.org/10.3390/electronics13142706.
2.    Malay Paul, H. S Keerthy, Mukesh Sharma, Pradeep Kumar Patel, Sowmya TP. A Review on Microspheres as Controlled Release Drug Delivery. Asian Journal of Pharmaceutical Research. 2023; 13(3): 163-8. doi: 10.52711/2231-5691.2023.00031.
3.    Mostafa M, Al Fatease A, Alany RG, Abdelkader H. Recent advances of ocular drug delivery systems: prominence of ocular implants for chronic eye diseases. Pharmaceutics. 2023 Jun 15; 15(6): 1746. https://doi.org/10.3390/pharmaceutics15061746.
4.    Pandey S, Biswas G. An Overview on Microspheres and Microcapsules as Promising Drug Carriers. PriMera Sci. Surg. Res. Pract. 2023; 2: 3-15. doi:10.56831/PSSRP-02-047.
5.    Dhadde Gurunath S., Mali Hanmant S., Raut Indrayani D., Nitalikar Manoj M., Bhutkar Mangesh A. A Review on Microspheres: Types, Method of Preparation, Characterization and Application. Asian Journal of Pharmacy and Technology. 2021; 11(2): 149-5. doi: 10.52711/2231-5713.2021.00025.
6.    Kállai-Szabó N, Farkas D, Lengyel M, Basa B, Fleck C, Antal I. Microparticles and multi-unit systems for advanced drug delivery. European Journal of Pharmaceutical Sciences. 2024 Jan 14: 106704. doi: 10.1016/j.ejps.2024.106704.
7.    Adwan S, Qasmieh M, Al-Akayleh F, Ali Agha AS. Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals. Pharmaceuticals. 2024 Oct 2; 17(10): 1315. doi: 10.3390/ph17101315.
8.    Tanmay Jit, Saptarshi Mukherjee, Sailee Chowdhury, Gouranga Nandi, Jashabir Chakraborty, Dibyendu Shil, Saumendu Deb Roy. Microsphere in Novel Drug Delivery System - A Descriptive Review. Asian Journal of Pharmacy and Technology. 2024; 14(4): 399-6. doi: 10.52711/2231-5713.2024.00063.
9.    Li Q, Chang B, Dong H, Liu X. Functional microspheres for tissue regeneration. Bioactive Materials. 2023 Jul 1; 25: 485-99. doi: 10.1016/j.bioactmat.2022.07.025.
10.    Lengyel M, Kállai-Szabó N, Antal V, Laki AJ, Antal I. Microparticles, Microspheres, and microcapsules for advanced drug delivery. Scientia Pharmaceutica. 2019; 87(3): 20. doi: 10.3390/scipharm87030020. 
11.    Khairnar S, Sanchez-Lopez E, Souto EB, Singh KK. Moxifloxacin loaded microspheres-composed gel for controlled release and enhanced penetration in ocular tissues: In vitro, ex vivo and in vivo proof of concept. Journal of Drug Delivery Science and Technology. 2023 Dec 1; 90: 105111. doi: 10.1016/j.jddst.2023.105111.
12.    Gurung BD, Kakar S. An overview on microspheres. Int J Health Clin Res. 2020; 3(1): 11-24. https://doi.org/10.22270/ajprd.v9i4.1003.
13.    Aprajita Shifali, Pravin Kumar, Vinay Pandit. Recent trends in Ocular Drug Delivery System: A Review. Asian J. Res. Pharm. Sci. 2021; 11(1): 71-80. doi: 10.5958/2231-5659.2021.00012.6.
14.    Ganju E, Prajapati S, Gupta BK. Mucoadhesive Microspheres: An Insight Review. Int J Med Phar Sci| Vol. 2024 Mar; 14(3): 3. doi: 10.31782/IJMPS.2024.14302
15.    Dhadde GS, Mali HS, Raut ID, Nitalikar MM, Bhutkar MA. A review on microspheres: types, method of preparation, characterization and application. Asian Journal of Pharmacy and Technology. 2021; 11(2): 149-55. doi:10.52711/2231-5713.2021.00025.
16.    Paul M, Keerthy HS, Sharma M, Patel PK, Sowmya TP. A Review on Microspheres as Controlled Release Drug Delivery. Asian Journal of Pharmaceutical Research. 2023; 13(3): 163-8. doi: 10.52711/2231-5691.2023.00031.
17.    Parente JF, Sousa VI, Marques JF, Forte MA, Tavares CJ. Biodegradable polymers for microencapsulation systems. Advances in Polymer Technology. 2022; 2022(1): 4640379. doi:10.1155/2022/4640379.
18.    Choudhury N, Meghwal M, Das K. Microencapsulation: An overview on concepts, methods, properties and applications in foods. Food Frontiers. 2021 Dec; 2(4): 426-42. https://doi.org/10.1002/fft2.94.
19.    Su Y, Zhang B, Sun R, Liu W, Zhu Q, Zhang X, Wang R, Chen C. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug delivery. 2021 Jan 1; 28(1): 1397-418. doi:10.1080/10717544.2021.1938756.
20.    Butreddy A, Gaddam RP, Kommineni N, Dudhipala N, Voshavar C. PLGA/PLA-based long-acting injectable depot microspheres in clinical use: production and characterization overview for protein/peptide delivery. International journal of molecular sciences. 2021 Aug 18;22(16):8884doi: 10.3390/ijms22168884.
21.    Li X, Li L, Wang D, Zhang J, Yi K, Su Y, Luo J, Deng X, Deng F. Fabrication of polymeric microspheres for biomedical applications. Materials Horizons. 2024.https://doi.org/10.1039/D3MH01641B.
22.    Yang C, Zhang Z, Gan L, Zhang L, Yang L, Wu P. Application of biomedical microspheres in wound healing. International Journal of Molecular Sciences. 2023 Apr 15; 24(8): 7319. doi: 10.3390/ijms24087319.
23.    Wang W. Microparticulate Drug Delivery Systems for Chinese Medicines. Novel Drug Delivery Systems for Chinese Medicines. 2021: 175-97. doi: 10.1007/978-981-16-3444-4_9.
24.    Wen K, Na X, Yuan M, Bazybek N, Li X, Wei Y, Ma G. Preparation of novel ropivacaine hydrochloride-loaded PLGA microspheres based on post-loading mode and efficacy evaluation. Colloids and Surfaces B: Biointerfaces. 2022 Feb 1; 210: 112215. doi: 10.1016/j.colsurfb.2021.112215.
25.    Bil M, Hipś I, Mrówka P, Święszkowski W. Studies on enzymatic degradation of multifunctional composite compriseing of chitosan microspheres and shape memory polyurethane matrix. Polymer Degradation and Stability. 2020 Dec 1;182:109392. doi:10.1016/j.polymdegradstab.2020.109392.
26.    Joiner JB, Prasher A, Young IC, Kim J, Shrivastava R, Maturavongsadit P, Benhabbour SR. Effects of drug physicochemical properties on in-situ forming implant polymer degradation and drug release kinetics. Pharmaceutics. 2022 Jun 1;14(6):1188.doi: 10.3390/pharmaceutics14061188.
27.    Bu QY, Chen Y, Ding Y, Zhang KX, Li YC, You XY, Zhao GP. Preparation and characterization of tea polyphenol composite microspheres encapsulated using sodium alginate and crosslinked starch. LWT. 2023 Jul 15; 184: 114888. doi: 10.1016/j.lwt.2023.114888.
28.    Wan B, Bao Q, Burgess DJ. In vitro-in vivo correlation of PLGA microspheres: Effect of polymer source variation and temperature. Journal of Controlled Release. 2022 Jul 1; 347: 347-55. https://doi.org/10.1016/j.jconrel.2022.05.014.
29.    Barar J, Aghanejad A, Fathi M, Omidi Y. Advanced drug delivery and targeting technologies for the ocular diseases. BioImpacts: BI. 2016; 6(1): 49. doi: 10.15171/bi.2016.07.
30.    Han, Haijie et al. “Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives.” Advanced drug delivery reviews vol. 196 (2023): 114770. doi: 10.1016/j.addr.2023.114770.
31.    Christian J.F. Bertens, Chiara Martino, Marty C. van Osch, Arno Lataster, Aylvin J.A.A. Dias, Frank J.H.M. van den Biggelaar, Remco Tuinier, Rudy M.M.A. Nuijts, Marlies Gijs, Design of the ocular coil, a new device for non-invasive drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2020; 150; 120-130.  https://doi.org/10.1016/j.ejpb.2020.03.010.
32.    Christian J. F. Bertens, Suryan L. Dunker, Aylvin J. A. A. Dias, Frank J. H. M. van den Biggelaar, Rudy M. M. A. Nuijts, Marlies Gijs; Safety and Comfort of an Innovative Drug Delivery Device in Healthy Subjects. Trans. Vis. Sci. Tech. 2020; 9(13): 35. https://doi.org/10.1167/tvst.9.13.35.
33.    Pijls, R. T., Sonderkamp, T., Daube, G. W., Krebber, R., Hanssen, H. H., Nuijts, R. M., Koole, L. H. Studies on a new device for drug delivery to the eye. European journal of pharmaceutics and biopharmaceutics: official Journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2005; 59(2): 283–288. https://doi.org/10.1016/j.ejpb.2004.08.011.
34.    Jantzen GM, Robinson JR. Sustained-and controlled-release drug delivery systems. Drugs and The Pharmaceutical Sciences. 2002; 121: 501-28. doi:10.1201/9780824744694.ch15.
35.    Kompella UB, Hartman RR, Patil MA. Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma. Progress in Retinal and Eye Research. 2021 May 1; 82: 100901. doi: 10.1016/j.preteyeres.2020.100901.
36.    Shashank R Gowda, Hindustan Abdul Ahad, Edukulla Satheesh Kumar, Athmika Sreedhara, Ranjitha Venkatesh, Amisha. Charting the Path of Success: A Deep Dive into Microspheres - A Comprehensive Review for Researchers Uncovering Triumphs, Innovations and Future Directions. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(4): 391-0. doi: 10.52711/2231-5659.2024.00062.
37.    Pawar PK, Rathod RD, Jagadale SR. A review on topical ophthalmic drug delivery system: Reference to viscosity enhancer. Polymers in Medicine. 2024; 54(1): 71-84.doi:10.17219/pim/166413.10.17219/pim/166413.
38.    Fang G, Yang X, Wang Q, Zhang A, Tang B. Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases. Materials Science and Engineering: C. 2021 Aug 1; 127: 112212.doi: 10.1016/j.msec.2021.112212.
39.    Yun J, Dinkin M. Current Endovascular Treatments in Neuro-Ophthalmology. Current Treatment Options in Neurology. 2024 Aug; 26(8): 355-71.doi:10.1007/s11940-024-00799-2.
40.    Gerberich BG, Hannon BG, Brown DM, Read AT, Ritch MD, Echeverri ES, Nichols L, Potnis C, Sridhar S, Toothman MG, Schwaner SA. Evaluation of spatially targeted scleral stiffening on neuroprotection in a rat model of glaucoma. Translational Vision Science and Technology. 2022 May 2; 11(5): 7-. doi: 10.1167/tvst.11.5.7.
41.    Tawfik M, Chen F, Goldberg JL, Sabel BA. Nanomedicine and drug delivery to the retina: Current status and implications for gene therapy. Naunyn-Schmiedeberg #39;s Archives of Pharmacology. 2022 Dec; 395(12): 1477-507. doi: 10.1007/s00210-022-02287-3.
42.    Sanomura T, Norikane T, Fujimoto K, Kawanishi M, Hoshikawa H, Nishiyama Y. A case of bleeding from maxillary carcinoma embolized from the maxillary and ophthalmic arteries. CVIR Endovascular. 2020 Dec; 3: 1-5. doi: 10.1186/s42155-020-00167-6.
43.    Shah SS, Denham LV, Elison JR, Bhattacharjee PS, Clement C, Huq T, Hill JM. Drug delivery to the posterior segment of the eye for pharmacologic therapy. Expert Review of Ophthalmology. 2010 Feb 1; 5(1): 75-93.doi: 10.1586/eop.09.70.
44.    Meijer TS, Burgmans MC, de Leede EM, de Geus-Oei LF, Boekestijn B, Handgraaf HJ, Hilling DE, Lutjeboer J, Vuijk J, Martini CH, van Erkel AR. Percutaneous hepatic perfusion with melphalan in patients with unresectable ocular melanoma metastases confined to the liver: a prospective phase II study. Annals of Surgical Oncology. 2021 Feb; 28: 1130-41. doi: 10.1245/s10434-020-08741-x.
45.    Luo LJ, Nguyen DD, Lai JY. Long-acting mucoadhesive thermogels for improving topical treatments of dry eye disease. Materials Science and Engineering: C. 2020 Oct 1; 115: 111095.doi: 10.1016/j.msec.2020.111095.
46.    Akhter MH, Ahmad I, Alshahrani MY, et al. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels. 2022; 8(2): 82. https://doi.org/10.3390/gels8020082.
47.    P. Usha Lakshmi, K. Tejaswini, B. Hemalatha, K. Padmalatha. Microspheres: A Comprehensive Review. Asian Journal of Research in Pharmaceutical Sciences. 2023; 13(3): 235-0. doi: 10.52711/2231-5659.2023.00041.
48.    Cabrera FJ, Wang DC, Reddy K, Acharya G, Shin CS. Challenges and opportunities for drug delivery to the posterior of the eye. Drug Discov Today. 2019; 24(8): 1679-1684. doi: 10.1016/j.drudis.2019.05.035.
49.    Giri BR, Jakka D, Sandoval MA, Kulkarni VR, Bao Q. Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies. Pharmaceutics. 2024; 16(10): 1325. doi: 10.3390/pharmaceutics16101325.
50.    Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, Singhvi G. Nanocarriers for ocular drug delivery: Current status and translational opportunity. RSC Advances. 2020; 10(46): 27835-55. doi: 10.1039/d0ra04971a.



Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.52711/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available